Skip to content

Examination of the Link Between Sun Exposure Routine and Bacteria Population of the Skin

Examination of the Link Between Sun Exposure Routine and Bacteria Population of the Skin

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02763163
Enrollment
100
Registered
2016-05-05
Start date
2016-05-31
Completion date
2016-09-30
Last updated
2016-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Brief summary

These days many studies are conducted testing the symbiosis between the bacteria population to the human body's functioning. The research of the connection between the skin condition and the bacteria population is in its early stages. There is a characterization of different bacteria for different body areas depending on their composition, humidity etc. In addition, there are preliminary findings of biological receptors that react to the contact with bacteria on the surface of the skin and turn on the immune system, awakening it to cope with the new invader. Based on the above information, the investigators hypothesis is that there is a connection between the degrees of sun exposure of individuals to the growing of beneficial bacteria populations on the surface of the skin. The study will compare between the bacteria population on the skin of Israeli subjects, divided to two groups, one with an excessive exposure to the sun on a daily basis, (such as agricultural workers, lifeguards, construction, etc.), and the other of the office worker who spend most of the day in a closed shaded room.

Interventions

BEHAVIORALSun exposure routine

Sponsors

Fischer Pharmaceuticals Ltd.
CollaboratorUNKNOWN
Institute for Skin Research, Israel
Lead SponsorINDUSTRY

Study design

Observational model
COHORT

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy volunteers between the age of 20-60.

Exclusion criteria

* Pregnant or lactating women. * Volunteers with a known allergy to one of the tested materials or to their ingredients. * Treatment with medication such as anti-inflammatories, antihistamines,corticosteroids, systemically or topically applied, unless stopped for 2 weeks prior to the trial in the case of systemic treatment and 3 days in the case of topical treatment.

Design outcomes

Primary

MeasureTime frame
Scanning the bacteria population of the surface of the skin by using swab on the cheek area. The samples of bacteria will be characterized by genetic sequencing.6 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026